Use of S-enantiomers of 1,4-dihydropyridine derivatives for trea

Details Use of S-enantiomers of 1,4-dihydropyridine derivatives for trea Use of S-enantiomers of 1,4-dihydropyridine derivatives for trea

1996-05-09

1997-12-09

Davis, Zinna Northington

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514339, 5462691, 546321, C07D21190, C07D41314, A61K 3144

Patent

active

056961391

ABSTRACT:
The present invention provides S-enantiomers of 1,4-dihydropyridines useful for the treatment of heart failure, preparation of compositions thereof and a method for the treatment of hypertension and heart failure comprising administration of these compounds.

REFERENCES:
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4705797 (1987-11-01), Nardi et al.
patent: 4772621 (1988-09-01), Nardi et al.
patent: 5091182 (1992-02-01), Ong et al.
Albertson, Org. React., 12:157 (1962).
Staab et al., Newer Methods Prep. Org. Chem., 5:61 (1968).
Ross, J. Cell Bio., 50:172 (1971).
Ross et al., Science 180:1332 (1973).
Wissler et al., Prog. Cardiovasc. Dis., 18:341 (1976).
Ross et al., N. Eng. J. Med., 295:369 (1976).
Gimbrone, Prog. Hemostasis Thromb., 3:1 (1976).
Brown et al., J. Biol. Chem., 255:9344 (1980).
Brown et al., Ann. Rev. Biochem., 52:233 (1983).
Edgell et al., Proc. Natl. Acad. Sci. USA, 80:3734 (1983).
Ross, J. Biol. Chem., 259:815 (1984).
Bianchi et al., Ircs Med. Sci., 14(8):817 (1986).
Schwartz et al., Cir. Res. 58:427 (1986).
Skalli et al., J. Cell Bio.,103:2787 (1986).
Bianchi et al., Pharmacol. Res., 21(2):193 (1989).
Clowes et al., J. Cardiov. Pharmacol., 14:S12, (1989).
Steinberg, et al., N. Eng. J. Med., 320:915 (1989).
Steinbrecher, Curr. Opin. Lipidol., 1:411 (1990).
Harrison et al., J. Lipid. Res., 31:2187-2193 (1990).
Wissler et al., Ann. NY Acad. Sci., 598:418 (1990).
Steinberg et al., JAMA, 264:3047 (1990).
E.L. Bierman in Harrison's Principle of Internal Medicine XII Ed., p. 992 (1991).
Goldmann et al., Agnew Chem. Int. Ed. Engl, 30:1559 (1991).
Yla-Herttuala, Ann. Med., 23:561 (1991).
Wissler et al., Am. J. Med., 91:(S1B), 1B-3S (1991).
Ashimori et al., Chem. Pharm. Bull., 39:108 (1991).
Steinberg, Circulation, 84:1420 (1991).
Kurihara et al., Curr. Opin. Lipidol, 2:295 (1991).
Corsini et al., Pharm. Res., 23:173 (1991).
Ishihara, Chem. Pharm. Bull., 39:3236 (1991).
Doherty et al., J. Med. Chem., 35:2-14 (1992).
Parthasarathy et al., Prog. Lipid Res., 31:127 (1992).
Bernini et al., Atherosclerosis,104:19 (1993).
De Lorenzi et al., Chirality, 5(8):622 (1993).
Ross, Nature, 362:801 (1993).
Hanna et al., Biochem. Pharmacol., 45:753 (1993).
Corsini et al., Atherosclerosis, 101:117 (1993).
Witztum, Lancet 344:793 (1994).
Maggi et al., Arteriosclerosis and Thromb., 14:1892 (1994).
Maggi et al., J. Hypertension, 13:129 (1995).
Drugs of the Future, 20(12):1284 (1995).

Affiliated with

Also associated with

Rating

Use of S-enantiomers of 1,4-dihydropyridine derivatives for trea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of S-enantiomers of 1,4-dihydropyridine derivatives for trea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of S-enantiomers of 1,4-dihydropyridine derivatives for trea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1608052